|
The investigation has determined that lower than expected vitros vancomycin (vanc) results were obtained from two different levels of non-vitros mas lot: cha24080 control fluids and the results obtained from the level 2 control met potential health and safety criteria.The results were obtained on a vitros xt7600 integrated system.The most likely assignable cause of the event was the vitros vanc reagent packs in use at the time of the event.The customer stated that during the timeframe of this event, the refrigerator where the vitros microtip reagents were stored, including the vitros vanc reagent, malfunctioned, and some reagent packs were frozen.It is possible the affected reagent packs were frozen.Per the vitros vanc instructions for use, only refrigerated storage is specified as acceptable.A systemic performance issue vitros vanc lot: 2514-49-9851 did not likely contribute to the event as acceptable vitros vanc results were obtained prior to the event using alternate reagent packs of the same reagent lot.In addition, continual tracking and trending of complaints has not identified any signals that would point to a potential systemic issue with vitros vanc lot: 2514-49-9851.A performance issue with the vitros xt7600 integrated system did not likely contribute to the event as diagnostic within-run precision testing was performed and the results indicated the vitros xt7600 integrated system was performing as intended.
|